Multitude Therapeutics

Multitude Therapeutics

Biotechnology Research

Redwood City, California 425 followers

About us

Multitude Therapeutics (MTX) is a spinoff company created by Abmart to leverage its unparalleled target and antibody discovery capability for cancer immunotherapy. MTX focuses on developing novel antibody-drug conjugates (ADC), CAR-Ts and immuno-oncology antibodies for solid and hematological tumors. MTX’s therapeutic programs are based on novel cancer and immune cell surface targets discovered by monoclonal antibody arrays (Human Membrane Proteome MabArrayTM or HMP-MabArrayTM) powered by the exceptional antibody discovery capabilities built at Abmart.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Redwood City, California
Type
Privately Held
Founded
2018
Specialties
MabArray platform based target discovery

Locations

Employees at Multitude Therapeutics

Updates

Similar pages

Browse jobs

Funding